Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Consider benefits and risks of new alopecia treatments for safety.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.